AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Sale
+$149,378
-79.49%
Shares
Shares Volume: 7,417 Shares
Average Share Price: $20.14
INSIDER
Krause Kevin Michael
Chief Strategy Officer (Officer)
reported on Jan 11 2024
traded on Jan 9 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 1,914 |
| PURCHASES/SALES 1Y | 0 / 2 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $100,674.17 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 2 / 29 |
| P/S VALUE RATIO | 3.767 |
| AVERAGE SALE VALUE | $146,964.43 |
| COMPANY PREVIOUS TRADES |